Epstein-Barr virus-related post-transplant lymphoproliferative disease (EBV-PTLD) in the setting of allogeneic stem cell transplantation: a comprehensive review from pathogenesis to forthcoming treatment modalities
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Epstein-Barr virus-related post-transplant lymphoproliferative disease (EBV-PTLD) in the setting of allogeneic stem cell transplantation: a comprehensive review from pathogenesis to forthcoming treatment modalities
Authors
Keywords
-
Journal
BONE MARROW TRANSPLANTATION
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-05-15
DOI
10.1038/s41409-019-0548-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Low dose Rituximab for pre-emptive treatment of Epstein Barr virus reactivation after allogenic hematopoietic stem cell transplantation
- (2019) B. Delapierre et al. Current Research in Translational Medicine
- Prophylactic rituximab prevents EBV PTLD in haplo-cord transplant recipients at high risk
- (2019) Koen Van Besien et al. LEUKEMIA & LYMPHOMA
- Frequency, characteristics and outcome of PTLD after allo-SCT: a multicenter study from the Spanish group of blood and marrow transplantation (GETH)
- (2019) I. García-Cadenas et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Management of post-transplant lymphoproliferative disorders
- (2018) Christin B. DeStefano et al. BRITISH JOURNAL OF HAEMATOLOGY
- Post-Transplantation Lymphoproliferative Disorders in Adults
- (2018) Daan Dierickx et al. NEW ENGLAND JOURNAL OF MEDICINE
- Impact on early outcomes and immune reconstitution of high-dose post-transplant cyclophosphamide vs anti-thymocyte globulin after reduced intensity conditioning peripheral blood stem cell allogeneic transplantation
- (2018) Christelle Retière et al. Oncotarget
- Response to Rituximab Induction Is a Predictive Marker in B-Cell Post-Transplant Lymphoproliferative Disorder and Allows Successful Stratification Into Rituximab or R-CHOP Consolidation in an International, Prospective, Multicenter Phase II Trial
- (2017) Ralf U. Trappe et al. JOURNAL OF CLINICAL ONCOLOGY
- Obinutuzumab or Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Previously Untreated Diffuse Large B-Cell Lymphoma
- (2017) Umberto Vitolo et al. JOURNAL OF CLINICAL ONCOLOGY
- Ofatumumab Versus Rituximab Salvage Chemoimmunotherapy in Relapsed or Refractory Diffuse Large B-Cell Lymphoma: The ORCHARRD Study
- (2017) Gustaaf W. van Imhoff et al. JOURNAL OF CLINICAL ONCOLOGY
- Two alternate strategies for innate immunity to Epstein-Barr virus: One using NK cells and the other NK cells and γδ T cells
- (2017) Zakia Djaoud et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Obinutuzumab for the First-Line Treatment of Follicular Lymphoma
- (2017) Robert Marcus et al. NEW ENGLAND JOURNAL OF MEDICINE
- Epstein–Barr virus-associated lymphomas
- (2017) Claire Shannon-Lowe et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- The Role of Antiviral Prophylaxis for the Prevention of Epstein-Barr Virus-Associated Posttransplant Lymphoproliferative Disease in Solid Organ Transplant Recipients: A Systematic Review
- (2016) M. A. AlDabbagh et al. AMERICAN JOURNAL OF TRANSPLANTATION
- EBV-Positive and EBV-Negative Posttransplant Diffuse Large B Cell Lymphomas Have Distinct Genomic and Transcriptomic Features
- (2016) J. Finalet Ferreiro et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Greatly reduced risk of EBV reactivation in rituximab-experienced recipients of alemtuzumab-conditioned allogeneic HSCT
- (2016) D M Burns et al. BONE MARROW TRANSPLANTATION
- Management of Epstein-Barr Virus infections and post-transplant lymphoproliferative disorders in patients after allogeneic hematopoietic stem cell transplantation: Sixth European Conference on Infections in Leukemia (ECIL-6) guidelines
- (2016) J. Styczynski et al. HAEMATOLOGICA
- Obinutuzumab plus bendamustine versus bendamustine monotherapy in patients with rituximab-refractory indolent non-Hodgkin lymphoma (GADOLIN): a randomised, controlled, open-label, multicentre, phase 3 trial
- (2016) Laurie H Sehn et al. LANCET ONCOLOGY
- Management of Epstein-Barr Virus infections and post-transplant lymphoproliferative disorders in patients after allogeneic hematopoietic stem cell transplantation: Sixth European Conference on Infections in Leukemia (ECIL-6) guidelines
- (2016) J. Styczynski et al. HAEMATOLOGICA
- The Impact of EBV Status on Characteristics and Outcomes of Posttransplantation Lymphoproliferative Disorder
- (2015) M. R. Luskin et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Epstein-Barr Virus–Related Post-Transplantation Lymphoproliferative Disorder after Unmanipulated Human Leukocyte Antigen Haploidentical Hematopoietic Stem Cell Transplantation: Incidence, Risk Factors, Treatment, and Clinical Outcomes
- (2015) Lan-Ping Xu et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Memory B-cell reconstitution following allogeneic hematopoietic stem cell transplantation is an EBV-associated transformation event
- (2015) D. M. Burns et al. BLOOD
- Randomized Phase II Trial Comparing Obinutuzumab (GA101) With Rituximab in Patients With Relapsed CD20+Indolent B-Cell Non-Hodgkin Lymphoma: Final Analysis of the GAUSS Study
- (2015) Laurie H. Sehn et al. JOURNAL OF CLINICAL ONCOLOGY
- Chemotherapy-Refractory Diffuse Large B-Cell Lymphoma and Indolent B-Cell Malignancies Can Be Effectively Treated With Autologous T Cells Expressing an Anti-CD19 Chimeric Antigen Receptor
- (2015) James N. Kochenderfer et al. JOURNAL OF CLINICAL ONCOLOGY
- The Missing Link in Epstein-Barr Virus Immune Evasion: the BDLF3 Gene Induces Ubiquitination and Downregulation of Major Histocompatibility Complex Class I (MHC-I) and MHC-II
- (2015) Laura L. Quinn et al. JOURNAL OF VIROLOGY
- Lenalidomide monotherapy leads to a complete remission in refractory B-cell post-transplant lymphoproliferative disorder
- (2015) Heinz Läubli et al. LEUKEMIA & LYMPHOMA
- HLA class I associations with EBV+ post-transplant lymphoproliferative disorder
- (2015) Kimberley Jones et al. TRANSPLANT IMMUNOLOGY
- Human Leukocyte Antigen Type and Posttransplant Lymphoproliferative Disorder
- (2015) Mark E. Lustberg et al. TRANSPLANTATION
- Establishment and operation of a Good Manufacturing Practice-compliant allogeneic Epstein-Barr virus (EBV)-specific cytotoxic cell bank for the treatment of EBV-associated lymphoproliferative disease
- (2014) Mark A. Vickers et al. BRITISH JOURNAL OF HAEMATOLOGY
- Comparison of different rabbit ATG preparation effects on early lymphocyte subset recovery after allogeneic HSCT and its association with EBV-mediated PTLD
- (2014) Angela Mensen et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Absence of Post-Transplantation Lymphoproliferative Disorder after Allogeneic Blood or Marrow Transplantation Using Post-Transplantation Cyclophosphamide as Graft-versus-Host Disease Prophylaxis
- (2013) Jennifer A. Kanakry et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Plasma Epstein-Barr virus DNA predicts outcome in advanced Hodgkin lymphoma: correlative analysis from a large North American cooperative group trial
- (2013) J. A. Kanakry et al. BLOOD
- EBV-associated post-transplant lymphoproliferative disorder following in vivo T-cell-depleted allogeneic transplantation: clinical features, viral load correlates and prognostic factors in the rituximab era
- (2013) C P Fox et al. BONE MARROW TRANSPLANTATION
- EBV-induced post transplant lymphoproliferative disorders: a persisting challenge in allogeneic hematopoetic SCT
- (2013) L Rasche et al. BONE MARROW TRANSPLANTATION
- Response to Rituximab-Based Therapy and Risk Factor Analysis in Epstein Barr Virus–Related Lymphoproliferative Disorder After Hematopoietic Stem Cell Transplant in Children and Adults: A Study From the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation
- (2013) Jan Styczynski et al. CLINICAL INFECTIOUS DISEASES
- Epstein-Barr virus reactivation in allogeneic stem cell transplantation is highly related to cytomegalovirus reactivation
- (2013) Francesco Zallio et al. CLINICAL TRANSPLANTATION
- EBV-Related Lymphomas: New Approaches to Treatment
- (2013) Jennifer A. Kanakry et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Risk factors for Epstein-Barr virus-related post-transplant lymphoproliferative disease after allogeneic hematopoietic stem cell transplantation
- (2013) M. Uhlin et al. HAEMATOLOGICA
- T-Cell–Replete HLA-Haploidentical Hematopoietic Transplantation for Hematologic Malignancies Using Post-Transplantation Cyclophosphamide Results in Outcomes Equivalent to Those of Contemporaneous HLA-Matched Related and Unrelated Donor Transplantation
- (2013) Asad Bashey et al. JOURNAL OF CLINICAL ONCOLOGY
- Preclinical Activity of the Type II CD20 Antibody GA101 (Obinutuzumab) Compared with Rituximab and Ofatumumab In Vitro and in Xenograft Models
- (2013) S. Herter et al. MOLECULAR CANCER THERAPEUTICS
- Post-Transplant Lymphoproliferative Disease (PTLD): Risk Factors, Diagnosis, and Current Treatment Strategies
- (2013) Zeina Al-Mansour et al. Current Hematologic Malignancy Reports
- Early Posttransplant Lymphoproliferative Disease
- (2012) Beverly P. Nelson et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Improved Early Outcomes Using a T Cell Replete Graft Compared with T Cell Depleted Haploidentical Hematopoietic Stem Cell Transplantation
- (2012) Stefan O. Ciurea et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Haploidentical Transplantation Using T Cell Replete Peripheral Blood Stem Cells and Myeloablative Conditioning in Patients with High-Risk Hematologic Malignancies Who Lack Conventional Donors is Well Tolerated and Produces Excellent Relapse-Free Survival: Results of a Prospective Phase II Trial
- (2012) Scott R. Solomon et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Unmanipulated Haploidentical Bone Marrow Transplantation and Posttransplantation Cyclophosphamide for Hematologic Malignancies after Myeloablative Conditioning
- (2012) Anna Maria Raiola et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER
- (2012) Lucie Kalinova et al. BIOMEDICAL PAPERS-OLOMOUC
- Clinical implications of plasma Epstein-Barr virus DNA in early-stage extranodal nasal-type NK/T-cell lymphoma patients receiving primary radiotherapy
- (2012) Z.-Y. Wang et al. BLOOD
- Pretreatment EBV-DNA Copy Number Is Predictive of Response and Toxicities to SMILE Chemotherapy for Extranodal NK/T-cell Lymphoma, Nasal Type
- (2012) Y. Ito et al. CLINICAL CANCER RESEARCH
- Regulation of CD20 in Rituximab-Resistant Cell Lines and B-cell Non-Hodgkin Lymphoma
- (2012) P.-C. Tsai et al. CLINICAL CANCER RESEARCH
- Post Transplant Lymphoproliferative Disorders: Risk, Classification, and Therapeutic Recommendations
- (2012) Deepa Jagadeesh et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Haploidentical bone marrow transplants for haematological malignancies using non-myeloablative conditioning therapy and post-transplant immunosuppression with cyclophosphamide: results from a single Australian centre
- (2012) I. A. Bilmon et al. INTERNAL MEDICINE JOURNAL
- Bruton Tyrosine Kinase Inhibitor Ibrutinib (PCI-32765) Has Significant Activity in Patients With Relapsed/Refractory B-Cell Malignancies
- (2012) Ranjana H. Advani et al. JOURNAL OF CLINICAL ONCOLOGY
- Increased Infection Rate After Preemptive Rituximab Treatment for Epstein-Barr Virus Reactivation After Allogeneic Hematopoietic Stem-Cell Transplantation
- (2012) Anna D. Petropoulou et al. TRANSPLANTATION
- Comparison of Different Suicide-Gene Strategies for the Safety Improvement of Genetically Manipulated T Cells
- (2012) Virna Marin et al. Human Gene Therapy Methods
- Tumor-specific but not nonspecific cell-free circulating DNA can be used to monitor disease response in lymphoma
- (2011) Kimberley Jones et al. AMERICAN JOURNAL OF HEMATOLOGY
- Association of HLA Polymorphisms with Post-transplant Lymphoproliferative Disorder in Solid-Organ Transplant Recipients
- (2011) R. Reshef et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Adoptive immunotherapy with unselected or EBV-specific T cells for biopsy-proven EBV+ lymphomas after allogeneic hematopoietic cell transplantation
- (2011) E. Doubrovina et al. BLOOD
- Features of EBV reactivation after reduced intensity conditioning unrelated umbilical cord blood transplantation
- (2011) Z Peric et al. BONE MARROW TRANSPLANTATION
- The Viral Load of Epstein-Barr Virus (EBV) DNA in Peripheral Blood Predicts for Biological and Clinical Characteristics in Hodgkin Lymphoma
- (2011) S. Hohaus et al. CLINICAL CANCER RESEARCH
- Comparison of six different specimen types for Epstein-Barr viral load quantification in peripheral blood of pediatric patients after heart transplantation or after allogeneic hematopoietic stem cell transplantation
- (2011) S. Ruf et al. JOURNAL OF CLINICAL VIROLOGY
- Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial
- (2011) Ralf Trappe et al. LANCET ONCOLOGY
- Horse versus Rabbit Antithymocyte Globulin in Acquired Aplastic Anemia
- (2011) Phillip Scheinberg et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rituximab Administration within 6 Months of T Cell-Depleted Allogeneic SCT is Associated with Prolonged Life-Threatening Cytopenias
- (2010) Zachariah McIver et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- The role of V 2-negative T cells during cytomegalovirus reactivation in recipients of allogeneic stem cell transplantation
- (2010) A. Knight et al. BLOOD
- Lymphomas differ in their dependence on Epstein-Barr virus
- (2010) D. T. Vereide et al. BLOOD
- Allogeneic haematopoietic stem-cell transplantation with reduced intensity conditioning for advanced stage Hodgkin's lymphoma in Sweden: high incidence of post transplant lymphoproliferative disorder
- (2010) J-E Johansson et al. BONE MARROW TRANSPLANTATION
- High incidence of post transplant lymphoproliferative disorder after antithymocyte globulin-based conditioning and ineffective prediction by day 28 EBV-specific T lymphocyte counts
- (2010) M Hoegh-Petersen et al. BONE MARROW TRANSPLANTATION
- Overcoming the barriers to umbilical cord blood transplantation
- (2010) Susan Staba Kelly et al. CYTOTHERAPY
- Multicenter Analysis of 80 Solid Organ Transplantation Recipients With Post-Transplantation Lymphoproliferative Disease: Outcomes and Prognostic Factors in the Modern Era
- (2010) Andrew M. Evens et al. JOURNAL OF CLINICAL ONCOLOGY
- Soluble CD30: A serum marker for Epstein-Barr virus-associated lymphoproliferative diseases
- (2010) Tanzina Haque et al. JOURNAL OF MEDICAL VIROLOGY
- Examining the Origin of Posttransplant Lymphoproliferative Disorder in a Patient After a Second Allogeneic Hematopoeitic Stem Cell Transplantation for Relapsed BCR-ABL Positive Acute Lymphoblastic Leukemia
- (2010) Stephanie Ruf et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
- (2009) Marcie Tomblyn et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Down-regulation of CD20 expression in B-cell lymphoma cells after treatment with rituximab-containing combination chemotherapies: its prevalence and clinical significance
- (2009) J. Hiraga et al. BLOOD
- Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation
- (2009) O. Landgren et al. BLOOD
- Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients
- (2009) H. E. Heslop et al. BLOOD
- Lymphoma After Solid Organ Transplantation: Risk, Response to Therapy, and Survival at a Transplantation Center
- (2009) Jason S. Knight et al. JOURNAL OF CLINICAL ONCOLOGY
- Outcome of treatment of Epstein-Barr virus-related post-transplant lymphoproliferative disorder in hematopoietic stem cell recipients: a comprehensive review of reported cases
- (2009) J. Styczynski et al. Transplant Infectious Disease
- Prospective Study of Sequential Reduction in Immunosuppression, Interferon Alpha-2B, and Chemotherapy for Posttransplantation Lymphoproliferative Disorder
- (2009) Lode J. Swinnen et al. TRANSPLANTATION
- Sirolimus in Pediatric Liver Transplantation: A Single-Center Experience
- (2009) N.E.M. Gibelli et al. TRANSPLANTATION PROCEEDINGS
- Post-transplantation Lymphoproliferative Disease
- (2008) Stephen A. Wheless et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Single agent lenalidomide induces a response in refractory T-cell posttransplantation lymphoproliferative disorder
- (2008) C. Portell et al. BLOOD
- Prior immunosuppressive therapy with antithymocyte globulin increases the risk of EBV-related lymphoproliferative disorder following allo-SCT for acquired aplastic anaemia
- (2008) H C E Buyck et al. BONE MARROW TRANSPLANTATION
- EBV reactivation and post transplant lymphoproliferative disorders following allogeneic SCT
- (2008) S Ocheni et al. BONE MARROW TRANSPLANTATION
- Poor outcome in post transplant lymphoproliferative disorder with pulmonary involvement after allogeneic hematopoietic SCT: 13 years' experience in a single institute
- (2008) H-A Hou et al. BONE MARROW TRANSPLANTATION
- Management of HSV, VZV and EBV infections in patients with hematological malignancies and after SCT: guidelines from the Second European Conference on Infections in Leukemia
- (2008) J Styczynski et al. BONE MARROW TRANSPLANTATION
- Epstein–Barr virus, rapamycin, and host immune responses
- (2008) Sheri M Krams et al. Current Opinion in Organ Transplantation
- Clinical and pathological prognostic markers for survival in adult patients with post-transplant lymphoproliferative disorders in solid transplant
- (2008) Ana B. Oton et al. LEUKEMIA & LYMPHOMA
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now